Tender detail
Open-house medicine rebate agreements for tiotropium bromide inhalation solution (ATC R03BB04)
Summary
The procurement concerns non-exclusive medicine rebate agreements for products containing tiotropium bromide in inhalation-solution form. Agreements cover the period from 1 February 2026 to 31 January 2028, with the possibility of joining at any time. Medicines included on the BfArM list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.